We are live on ! Find out more
Westfield Capital Management

Westfield Capital Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 49.45%
This Fund
S&P 500
This Quarter Est. Return
+12.52%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$15.6B
AUM Growth
+$1.1B
Cap. Flow
-$339M
Cap. Flow %
-2.17%
Top 10 Hldgs %
15.78%
Holding
393
New
35
Increased
71
Reduced
176
Closed
47

Top Buys

Rank Stock Value
1
VPHM
VIROPHARMA INC
VPHM
+$137M
2
AMGN icon
Amgen
AMGN
+$130M
3
AME icon
Ametek
AME
+$116M
4
ALTR
Altera Corp
ALTR
+$92M
5
META icon
Meta Platforms (Facebook)
META
+$83.3M

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$117M
2
PFE icon
Pfizer
PFE
+$110M
3
NKE icon
Nike
NKE
+$108M
4
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$86.1M
5
OXY icon
Occidental Petroleum
OXY
+$74.3M

Sector Composition

Rank Sector Weight
1 Healthcare 15.99%
2 Consumer Discretionary 15.07%
3 Industrials 12.48%
4 Technology 12.03%
5 Communication Services 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARAY icon
301
Accuray
ARAY
$33.8M
$555K ﹤0.01%
75,200
– –
CL icon
302
Colgate-Palmolive
CL
$74.1B
$528K ﹤0.01%
8,910
– –
PG icon
303
Procter & Gamble
PG
$342B
$518K ﹤0.01%
6,857
-260
-4% -$20.7K
RSE
304
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
$515K ﹤0.01%
25,000
– –
VVTV
305
DELISTED
VALUEVISION MEDIA INC
VVTV
$490K ﹤0.01%
112,400
– –
SGMO
306
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$486K ﹤0.01%
46,300
+24,700
+114% +$245K
IPHI
307
DELISTED
INPHI CORPORATION
IPHI
$478K ﹤0.01%
35,600
– –
SNAK
308
DELISTED
Inventure Foods, Inc.
SNAK
$470K ﹤0.01%
44,800
– –
JBTM
309
JBT Marel
JBTM
$6.36B
$468K ﹤0.01%
18,800
– –
CALX icon
310
Calix
CALX
$2.36B
$435K ﹤0.01%
34,200
– –
UNP icon
311
Union Pacific
UNP
$175B
$435K ﹤0.01%
5,600
– –
CB
312
DELISTED
CHUBB CORPORATION
CB
$427K ﹤0.01%
4,779
– –
EGL
313
DELISTED
Engility Holdings, Inc.
EGL
$422K ﹤0.01%
13,300
– –
PLOW icon
314
Douglas Dynamics
PLOW
$1.04B
$411K ﹤0.01%
27,900
– –
KG
315
Kestrel Group
KG
$69.7M
$390K ﹤0.01%
1,650
– –
KO icon
316
Coca-Cola
KO
$374B
$387K ﹤0.01%
10,210
-2,969,642
-100% -$117M
FIO
317
DELISTED
FUSION-IO INC COM
FIO
$386K ﹤0.01%
+28,840
New +$380K
ARII
318
DELISTED
American Railcar Industries, Inc.
ARII
$377K ﹤0.01%
9,600
-190,884
-95% -$6.81M
MWA icon
319
Mueller Water Products
MWA
$4.24B
$376K ﹤0.01%
47,000
+16,400
+54% +$126K
USPH icon
320
US Physical Therapy
USPH
$1.16B
$376K ﹤0.01%
12,100
– –
NEU icon
321
NewMarket
NEU
$8.21B
$371K ﹤0.01%
1,290
– –
MDT icon
322
Medtronic
MDT
$110B
$369K ﹤0.01%
6,934
-100
-1% -$5.38K
CSII
323
DELISTED
Cardiovascular Systems, Inc.
CSII
$367K ﹤0.01%
18,300
– –
CBM
324
DELISTED
Cambrex Corporation
CBM
$355K ﹤0.01%
26,900
– –
CBRL icon
325
Cracker Barrel
CBRL
$1.3B
$346K ﹤0.01%
3,350
– –
11 12
13
14 15

Similar funds

Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Westfield Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Westfield Capital Management held 393 positions worth $15.6B, up 7.6% from $14.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Westfield Capital Management's Q3 2013 filing shows 35 new, 71 increased, 176 reduced and 47 closed positions. Its largest new stake was Amgen: 1,202,551 shares worth $135M. The largest sale was Coca-Cola, an estimated $117M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Westfield Capital Management's largest Q3 2013 buy was Amgen: 1,202,551 shares worth $135M.
  • Westfield Capital Management added most to VIROPHARMA INC in Q3 2013, an estimated $137M increase.
  • Westfield Capital Management's biggest Q3 2013 reduction was Coca-Cola, cutting an estimated $117M.
  • Westfield Capital Management fully exited Nike in Q3 2013, selling an estimated $108M.
  • Westfield Capital Management's ten largest holdings make up 16% of its $15.6B portfolio in Q3 2013.
  • Westfield Capital Management opened 35 new positions and closed 47 in Q3 2013.
  • Westfield Capital Management's portfolio value rose 7.6% quarter-over-quarter to $15.6B.

Based on Westfield Capital Management's 13F filing for Q3 2013, filed 12 Nov 2013.